Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Naltrexone/Bupropion on Metformin PK
NCT02745912Phase 1Completed
- Sponsor
- Orexigen Therapeutics
- Start
- Apr 2016
- Primary completion
- Jun 2016
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of naltrexone + bupropion in obesity, sponsored by Orexigen Therapeutics. Primary endpoints: Maximum Observed Plasma Concentration of Metformin at Day 14 and Area Under the Plasma Concentration-time Curve of Metformin at Day 14. Started Apr 2016; status: completed.
02
Drugs
naltrexone + bupropion
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02745912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02745912.